SEMA3F and breast carcinoma: By contrast, SEMA3F and its receptor, NRP-2, have roles in cell migration; for example, SEMA3F gradients had repulsive effects on the migration of thymocytes [20] and the highly motile C100 breast cancer cells [21]—an effect that was blocked by an anti-NRP-2 antibody.